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ReseaRch Methods and RepoRting
STARD for Abstracts: essential items for reporting diagnostic 
accuracy studies in journal or conference abstracts
Jérémie F Cohen,1,2 Daniël A Korevaar,1 Constantine A Gatsonis,3 Paul P Glasziou,4 Lotty Hooft,5 
David Moher,6,7 Johannes B Reitsma,8 Henrica CW de Vet,9 Patrick M Bossuyt1
Many abstracts of diagnostic accuracy 
studies are currently insufficiently 
informative. We extended the STARD 
(Standards for Reporting Diagnostic 
Accuracy) statement by developing a 
list of essential items that authors 
should consider when reporting 
diagnostic accuracy studies in journal 
or conference abstracts. After a 
literature review of published guidance 
for reporting biomedical studies, we 
identified 39 items potentially relevant 
to report in an abstract. We then 
selected essential items through a two 
round web based survey among the 85 
members of the STARD Group, followed 
by discussions within an executive 
committee. Seventy three STARD Group 
members responded (86%), with 100% 
completion rate. STARD for Abstracts is 
a list of 11 quintessential items, to be 
reported in every abstract of a 
diagnostic accuracy study. We provide 
examples of complete reporting, and 
developed template text for writing 
informative abstracts.
Abstracts play a critical role in the use of research. 
Clinicians and researchers use abstracts to decide 
whether they should read the full journal article, 
attend the conference presentation, or contact the 
authors for more information. Systematic reviewers 
screen large amounts of abstracts to assess study 
eligibility. In some cases, study abstracts may be the 
only information available to clinicians, researchers, 
reviewers, guideline developers, or policy makers.1 
In evaluations, the proportion of diagnostic accuracy 
studies presented as conference abstracts that are 
eventually reported in articles was found to be as low 
as 39%.2-4
We recently evaluated the quality of reporting of 
abstracts of diagnostic accuracy studies published in 
several high impact journals and abstracts presented 
at a major ophthalmology conference.5 6 In line with 
previous authors,3 7 we found that many of these 
abstracts were insufficiently informative. Key items, 
such as eligibility criteria, study setting, patient 
sampling procedures, and confidence intervals around 
accuracy estimates were reported in less than half 
of the abstracts.5 6 This makes it difficult for readers 
to assess the validity and applicability of the study 
findings.
Ideally, studies should be free from deficiencies, 
and the results of the study should reflect the “true” 
accuracy of the test under evaluation. Major sources 
of bias in diagnostic accuracy studies include 
methodological flaws in participant recruitment, data 
collection, test execution and interpretation, and data 
analysis.8 9 Even when free of bias, study findings 
are not necessarily generalisable to all applications. 
Diagnostic accuracy can vary across studies because of 
variations in study setting, participant characteristics, 
disease prevalence and severity, and aspects of test 
execution and interpretation.10 Risk of bias and 
concerns about applicability can only be evaluated if 
study reports are sufficiently informative.
Aim and scope
The Standards for Reporting Diagnostic Accuracy 
(STARD) initiative was developed in response to 
increasing evidence of suboptimal reporting of 
diagnostic accuracy studies in scientific journals.8 9 
The STARD Group developed a list of essential items 
that should be presented in all full reports of diagnostic 
accuracy studies.11 Since its launch in 2003, STARD has 
been endorsed by more than 200 journals, including The 
BMJ. Study reports of diagnostic accuracy studies have 
become more complete since then, although there is still 
room for further improvement.12 STARD 2015, an update 
of the original STARD statement, was recently published 
by The BMJ, Radiology, and Clinical Chemistry.13-15
Unlike some other reporting guidelines, such as 
CONSORT (Consolidated Standards Of Reporting 
Trials) for randomised controlled trials1 and PRISMA 
(Preferred Reporting Items for Systematic reviews and 
Meta-analyses) for systematic reviews,16 STARD so far 
has not provided guidance for writing abstracts. Here 
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SummAry pointS
•   The STARD statement has become an internationally accepted reporting 
guideline for diagnostic accuracy studies
•   STARD for Abstracts is intended to improve the completeness and 
informativeness of journal and conference abstracts of diagnostic accuracy 
studies
•   STARD for Abstracts presents a minimal set of 11 items (specific journals 
or organisations could ask for additional information); whenever space 
restrictions allow it, authors may also incorporate other STARD 2015 elements 
in their abstract
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we present a separate reporting guideline that can 
help to improve the informativeness of abstracts of 
diagnostic accuracy studies, both for journals and for 
conferences.
The guiding principle in the development of the 
checklist was to identify essential items that should be 
reported in all abstracts of diagnostic accuracy studies, 
considering the usual 200 to 300 word limit. The items 
can assist authors in presenting informative abstracts and 
help readers in deciding whether to invest time in reading 
the full report, attending the conference presentation, or 
contacting the authors for more information.
methods for developing StArD for Abstracts
Detailed survey methods and results are presented in 
supplementary eAppendix 1 and eTables 1 and 2. We 
relied on standard processes for developing reporting 
guidelines.17 Initially we formed an executive 
committee (DAK and JFC, clinicians, respectively, 
doctoral and postdoctoral research fellows; PMB, 
CAG, JBR, and LH, respectively, professor in clinical 
epidemiology, professor in biostatistics, associate 
professor in clinical epidemiology, and co-director of 
the Dutch Cochrane Centre) and developed a protocol.18 
We then conducted a literature review, which focused 
on previously published guidance for reporting 
biomedical studies (full texts and abstracts), including 
STARD 2015, and on studies of the methodological 
quality of diagnostic accuracy studies.5 Thereafter we 
listed 39 items judged potentially relevant to report in 
abstracts (see supplementary eAppendix 2).
We then invited the STARD Group, which consists 
of 85 clinical epidemiologists, statisticians, journal 
editors, and other stakeholders, to participate in a 
two round web based survey, aiming at obtaining 
consensus on which of these items were deemed 
essential.
Seventy three STARD Group members responded 
in both rounds (86%), with 100% completion rate. 
In the first round, participants were asked to rate to 
what extent each candidate item would be essential for 
abstracts. Consensus, defined as a positive response 
by at least two thirds of the respondents, was reached 
for 10 items. We then developed a draft STARD for 
Abstracts checklist and circulated it within the STARD 
Steering Committee. That list was fine tuned until the 
executive committee agreed.
In the second round, STARD Group members were 
asked whether they thought any of the remaining 
candidate items, apart from the 10 selected in the first 
round, should be added to the list. No consensus was 
reached about adding any other item. In both rounds 
of the survey, participants had the option to provide 
comments in open comment boxes.
After the survey, a revised draft STARD for Abstracts 
checklist was established. During a teleconference 
in August 2015, the executive committee agreed on 
incorporating two additional elements, merging these 
into the already selected items. This was based on 
concerns expressed in comments by STARD Group 
members during the survey. The draft list of 10 
items was then circulated to members of the STARD 
Steering Committee to provide feedback. Before the 
final list was agreed upon, the executive committee 
decided to add an 11th item about study registration 
(see supplementary eAppendix 3 for a description 
of the flow of items through the process), to ensure 
consistency with another STARD initiative promoting 
the prospective registration of diagnostic accuracy 
studies.19
StArD for Abstracts
STARD for Abstracts presents a checklist of 11 
essential items, to be considered in every abstract 
Table 1 | STARD for Abstracts: essential items for reporting diagnostic accuracy studies in journal or conference 
abstracts
Section Item
Identification as a study of diagnostic accuracy using at least one measure of accuracy (such as sensitivi-
ty, specificity, predictive values, or AUC)
Background and Objectives Study objectives
Methods Data collection: whether this was a prospective or retrospective study
Eligibility criteria for participants and settings where the data were collected
Whether participants formed a consecutive, random, or convenience series
Description of the index test and reference standard
Results Number of participants with and without the target condition included in the analysis
Estimates of diagnostic accuracy and their precision (such as 95% confidence intervals)
Discussion General interpretation of the results
Implications for practice, including the intended use of the index test
Registration Registration number and name of registry
AUC=area under the curve.
Table 2 | Key STARD terminology
Term Explanation
Index test The test under evaluation
Target condition The disease, disease stage, event, or condition that the index test is expected to detect
Reference standard The test or procedure used for establishing the presence or absence of the target condition
Intended use of the test Whether the index test is used for diagnosis, screening, staging, monitoring, surveillance, prediction, progno-
sis, or other reasons
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that reports on a diagnostic accuracy study (see table 
1 for the checklist and table 2 for key terminology). 
The structure of STARD for Abstracts follows that of a 
typical biomedical abstract, with headings pertaining 
to Background and Objectives, Methods, Results, and 
Discussion sections.
Because 10 out of 11 STARD for Abstracts items are 
similar to those from STARD 2015 (see supplementary 
eTable 3), we did not develop a separate explanation 
and elaboration document; instructions can be found 
in STARD 2015.20 To illustrate the information that 
corresponds to each item, we collected examples of 
complete reporting (see supplementary eAppendices 
4-7). To further assist authors in writing abstracts, we 
developed template text for each item and an example 
abstract (see table 3 for template text and the box for 
an example of application).
Applicability and implementation
In developing STARD for Abstracts, we aimed at 
identifying items that would apply to any abstract of a 
diagnostic accuracy study. The list presents a minimum, 
and specific journals or organisations could ask for 
additional information, such as variability across 
readers in imaging studies or analytical performance 
in laboratory tests studies. Whenever space restrictions 
allow it, authors may incorporate other elements from 
STARD 2015 in their abstract.
Based on our evaluations, we believe it is possible to 
address all 11 items within the 200 to 300 word limit 
that typically applies for abstracts (supplementary 
eAppendices 4-7 illustrate real abstracts, with 237 to 
339 words, which comply well with the checklist). We 
do not make recommendations about how abstracts 
should be structured but only recommend that this 
Table 3 | STARD for Abstracts template text
STARD for Abstracts item Template text
Identification as a study of diagnostic accuracy using 
at least one measure of accuracy (such as sensitivity, 
specificity, predictive values, or AUC)
[diagnostic accuracy/sensitivity and specificity/predictive value . . . ] of [index test] for diagnosing [target condition]
Study objectives to evaluate the [diagnostic accuracy/sensitivity and specificity/predictive value . . . ] of [index test] in patients with 
suspected [target condition]
Data collection: whether this was a prospective or 
retrospective study
  •   In this [prospective/retrospective] study . . .
  •   We conducted a [prospective/retrospective] study. . .
  •   Data were collected [prospectively/retrospectively] . . .
Eligibility criteria for participants and the settings 
where the data were collected
eligible for inclusion were [adults/children/men/women] [age X to Y years] with suspected [target condition] . . .
  •   based on [presenting signs and symptoms]
  •   who underwent [index test] and [reference standard]
[mono/multi]centre study in [primary/secondary/tertiary] care in [country] . . .
Whether participants formed a consecutive, random, or 
convenience series
a [consecutive series/random sample/convenience sample] of patients with . . .
Description of the index test and reference standard   •   all patients underwent [index test with key elements of description] . . . 
  •   [reference standard with key elements of description] was used as the reference standard . . .
Number of participants with and without the target 
condition included in the analysis
Of [X] patients included in the analysis, the diagnosis of [target condition] was confirmed in [Y] and excluded in [Z]
Estimates of diagnostic accuracy and their precision 
(such as 95% confidence intervals)
The [sensitivity and specificity/positive and negative predictive values/positive and negative likelihood ratios] of [index 
test] were [A (95% CI B to C)] and [D (95% CI E to F)], respectively
General interpretation of the results [Index test] showed [high/low/insufficient . . . ] [accuracy/sensitivity/specificity . . . ] for detecting/diagnosing [target 
condition]
Implications for practice, including the intended use of 
the index test
[Index test] [should/should not/could/could not . . . ] be used for [diagnosis/screening/staging/monitoring/surveillance 
. . . ] in [patients/adults/children] suspected of [target condition] seen in [primary/secondary/tertiary] care
Registration number and name of registry [Name of registry]: [Registration number]
AUC=area under the curve
Box 1: Example of an application of STARD for Abstracts template text
Point-of-care D-Dimer testing for diagnosing pulmonary embolism in primary care
•   Objective: To evaluate the negative and positive predictive value of D-Dimer testing in patients with suspected pulmonary embolism in primary 
care.
•   Methods: We conducted a prospective study among 70 general practitioners in the UK. Eligible for inclusion were consecutive adults, age 18 to 
70 years, with suspected pulmonary embolism based on presenting signs and symptoms. All consenting patients underwent a qualitative 
point-of-care D-Dimer test (with a positivity cut-off of 80 ng/mL) performed by the general practitioner. Patients with a positive D-Dimer test 
result were referred to secondary care for further management according to national guidelines. Three months’ clinical follow-up was used as 
the reference standard in patients with a negative D-Dimer test result.
•   Results: Of 500 patients included in the analysis, the diagnosis of pulmonary embolism was confirmed in 50 and excluded in 450. Three cases of 
pulmonary embolism were observed among the 273 patients with negative D-Dimer test results. The negative predictive value of point-of-care 
D-dimer testing was 98.9% (95% confidence interval 96.8% to 99.8%) and the positive predictive value was 20.7% (15.6% to 26.6%).
•   Discussion: With a high negative predictive value, point-of-care D-Dimer testing could be used for the triage of adults suspected of pulmonary 
embolism seen in primary care.
•   Registration: ClinicalTrials.gov: NCT02593219.
•   Word count: 205
This abstract was created for illustrative purposes only. It is based on a virtual study.
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minimal set of information should be reported within 
every abstract. Some conferences invite authors 
to provide a figure with their abstract. If so, we 
recommend considering submission of a diagram 
reflecting the design and flow of participants through 
the study.13
To improve the completeness of reporting, simply 
developing a list of items is insufficient; dissemination, 
endorsement, and implementation are also critical.17 21 
We invite journal editors and conference organisers to 
endorse STARD for Abstracts, by drawing attention to 
this list of items in their instructions to authors and 
conference websites. The template texts may also 
facilitate writing abstracts of diagnostic accuracy 
studies (see table 3 and the box).
Conclusions
We acknowledge that an important share of the burden 
of improving reporting and reducing waste in research 
is currently put on journal editors and peer reviewers, 
as they play a major role in the final stages of the 
publication process. Authors should also take action, 
as should other stakeholders, such as funders and 
academic institutions.22 We need to convince scientific 
institutions and universities that complete reporting 
forms an irrefutably indispensable element of good 
research practice and should be taught as such in 
academic training programmes—for example, as part 
of scientific writing courses.21 23
We believe that STARD for Abstracts can help to 
improve the quality of reporting of diagnostic accuracy 
studies through the inclusion of essential study 
information in every abstract, thereby increasing 
the value of such studies to the clinical and research 
community.
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